Financhill
Sell
42

CLDX Quote, Financials, Valuation and Earnings

Last price:
$26.81
Seasonality move :
15.7%
Day range:
$26.39 - $26.95
52-week range:
$14.40 - $30.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
685.06x
P/B ratio:
2.98x
Volume:
221.2K
Avg. volume:
762.9K
1-year change:
6.76%
Market cap:
$1.8B
Revenue:
$7M
EPS (TTM):
-$3.38

CLDX Analysts' Consensus Rating

The 14 analysts providing 12-month price projections for Celldex Therapeutics, Inc. shares anticipate an average target of $53.36, ranging from a low estimate of $24.00 to a high estimate of $90.00. This average target implies a growth of 98.87% compared to the current stock price of $26.83.

Consensus Price Target

$53.36

Highest Price Target

$90.00

Lowest Price Target

$24.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 11 12 12

Hold 2 2 2

Sell 0 0 0
Consensus Buy Buy Buy

CLDX Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock